日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Drosophila pseudoobscura pseudoobscura Protein fuzzy homolog (fuz) CSB-YP640015DME
CSB-EP640015DME
CSB-BP640015DME
CSB-MP640015DME
CSB-EP640015DME-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana UDP-galactose/UDP-glucose transporter 2 (UTR2), partial CSB-YP640016DOA
CSB-EP640016DOA
CSB-BP640016DOA
CSB-MP640016DOA
CSB-EP640016DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bovine Peroxisomal NADH pyrophosphatase NUDT12 (NUDT12) CSB-YP640017BO
CSB-EP640017BO
CSB-BP640017BO
CSB-MP640017BO
CSB-EP640017BO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bovine TBC1 domain family member 24 (TBC1D24), partial CSB-YP640018BO
CSB-EP640018BO
CSB-BP640018BO
CSB-MP640018BO
CSB-EP640018BO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bovine WD repeat-containing protein 67 (WDR67), partial CSB-YP640019BO
CSB-EP640019BO
CSB-BP640019BO
CSB-MP640019BO
CSB-EP640019BO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bovine Protein fem-1 homolog A (FEM1A), partial CSB-YP640020BO
CSB-EP640020BO
CSB-BP640020BO
CSB-MP640020BO
CSB-EP640020BO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bovine Cytoplasmic dynein 1 intermediate chain 1 (DYNC1I1), partial CSB-YP640021BO
CSB-EP640021BO
CSB-BP640021BO
CSB-MP640021BO
CSB-EP640021BO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bovine Lipid phosphate phosphatase-related protein type 2 (LPPR2), partial CSB-YP640022BO1
CSB-EP640022BO1
CSB-BP640022BO1
CSB-MP640022BO1
CSB-EP640022BO1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bovine Peroxisomal sarcosine oxidase (PIPOX) CSB-YP640023BO
CSB-EP640023BO
CSB-BP640023BO
CSB-MP640023BO
CSB-EP640023BO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bovine N-acetylneuraminate lyase (NPL) CSB-YP640024BO
CSB-EP640024BO
CSB-BP640024BO
CSB-MP640024BO
CSB-EP640024BO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bovine NEDD4-binding protein 2-like 1 (N4BP2L1) CSB-YP640025BO
CSB-EP640025BO
CSB-BP640025BO
CSB-MP640025BO
CSB-EP640025BO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bovine Uncharacterized protein C3orf14 homolog CSB-YP640026BO
CSB-EP640026BO
CSB-BP640026BO
CSB-MP640026BO
CSB-EP640026BO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter jejuni subsp. jejuni serotype O:23/36 Aspartate 1-decarboxylase (panD) CSB-YP640027CWF
CSB-EP640027CWF
CSB-BP640027CWF
CSB-MP640027CWF
CSB-EP640027CWF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Francisella tularensis subsp. holarctica D-alanine--D-alanine ligase (ddl) CSB-YP640028FCO
CSB-EP640028FCO
CSB-BP640028FCO
CSB-MP640028FCO
CSB-EP640028FCO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Francisella tularensis subsp. holarctica NADH-quinone oxidoreductase subunit C (nuoC) CSB-YP640029FCO
CSB-EP640029FCO
CSB-BP640029FCO
CSB-MP640029FCO
CSB-EP640029FCO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Francisella tularensis subsp. holarctica Translation initiation factor IF-2 (infB), partial CSB-YP640030FCO
CSB-EP640030FCO
CSB-BP640030FCO
CSB-MP640030FCO
CSB-EP640030FCO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Francisella tularensis subsp. holarctica ATP synthase epsilon chain (atpC) CSB-YP640031FCO
CSB-EP640031FCO
CSB-BP640031FCO
CSB-MP640031FCO
CSB-EP640031FCO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Francisella tularensis subsp. holarctica DNA-directed RNA polymerase subunit beta (rpoB), partial CSB-YP640032FCO
CSB-EP640032FCO
CSB-BP640032FCO
CSB-MP640032FCO
CSB-EP640032FCO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Francisella tularensis subsp. holarctica RNA pyrophosphohydrolase (rppH) CSB-YP640033FCO
CSB-EP640033FCO
CSB-BP640033FCO
CSB-MP640033FCO
CSB-EP640033FCO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Francisella tularensis subsp. holarctica Tetraacyldisaccharide 4'-kinase (lpxK) CSB-YP640034FCO
CSB-EP640034FCO
CSB-BP640034FCO
CSB-MP640034FCO
CSB-EP640034FCO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×